相关实验视频

Updated: May 11, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

27.4K

病例报告:Temozolomide诱导的高突变表明质瘤患者对免疫治疗的不良反应

Jiapeng Liu1, Shuli Hu1, Haihui Jiang1

  • 1Department of Neurosurgery, Peking University Third Hospital, Peking University, Beijing, China.

Frontiers in immunology
|May 1, 2024
PubMed
概括

在质瘤患者中,长期使用temozolomide (TMZ) 治疗可能会诱导高突变. 这种TMZ诱导的高突变可能表明免疫治疗的反应不佳,突显了结质瘤治疗中的复杂关系.

关键词:
质瘤 质瘤 是一种过度突变是一种超级突变.免疫反应的免疫反应免疫疗法 免疫疗法泰莫索洛米德 (temozolomide) 是一种有毒的物质.

更多相关视频

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.4K
The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

18.0K

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.